The Cigna Group reported a $739 million third quarter net income despite a $1 billion loss on its investment in ...

Cigna surpassed quarterly profit estimates on Thursday, driven by strong demand for its specialty drugs and new clients for ...

Cigna surpassed Wall Street estimates for third-quarter profit on Thursday, driven by high demand for biosimilars of a ...

The Cigna Group posted strong Q3 2024 results, yet CI stock is down nearly 20% from its 52-week high. See why this may ...

Verdence Capital Advisors LLC trimmed its position in The Cigna Group (NYSE:CI – Free Report) by 36.0% in the third quarter, ...

CI's strong third-quarter results benefit from a strong Evernorth Health Services segment. Higher expenses partially offset ...

On Thursday, Cigna Corporation (NYSE:CI) reported third-quarter sales of $63.7 billion, up 30% year-over-year, beating the ...

The Cigna Group on Thursday reported a nearly $740 million profit for the third quarter of 2024, despite an after-tax loss of ...

Equities researchers at Leerink Partnrs dropped their FY2024 earnings per share estimates for shares of The Cigna Group in a ...

The Cigna Group (NYSE: CI) has reported robust financial results for the third quarter of 2024, showcasing a significant ...

Cigna exceeded quarterly profit projections, fueled by high demand for specialty drugs and new clients in its pharmacy benefit management sector. The company enjoyed a 2% premarket share increase and ...

Ballad Health announced this week it was continuing to negotiate with Cigna regarding a new agreement for the Cigna Medicare Advantage, Marketplace Exchange, Commercial, and Evernorth (behavioral ...